These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 24852726

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Problem sites: scalp, palm and sole, and nail.
    Larko O.
    Dermatol Clin; 1995 Oct; 13(4):771-7. PubMed ID: 8785882
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of Guselkumab Compared With Adalimumab and Placebo for Psoriasis in Specific Body Regions: A Secondary Analysis of 2 Randomized Clinical Trials.
    Foley P, Gordon K, Griffiths CEM, Wasfi Y, Randazzo B, Song M, Li S, Shen YK, Blauvelt A.
    JAMA Dermatol; 2018 Jun 01; 154(6):676-683. PubMed ID: 29799960
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Spanish evidence-based guidelines on the treatment of psoriasis with biologic agents, 2013. Part 1: on efficacy and choice of treatment. Spanish Psoriasis Group of the Spanish Academy of Dermatology and Venereology.
    Puig L, Carrascosa JM, Carretero G, de la Cueva P, Lafuente-Urrez RF, Belinchón I, Sánchez-Regaña M, García-Bustínduy M, Ribera M, Alsina M, Ferrándiz C, Fonseca E, García-Patos V, Herrera E, López-Estebaranz JL, Marrón SE, Moreno JC, Notario J, Rivera R, Rodriguez-Cerdeira C, Romero A, Ruiz-Villaverde R, Taberner R, Vidal D, Spanish Psoriasis Group of the Spanish Academy of Dermatology and Venereology.
    Actas Dermosifiliogr; 2013 Oct 01; 104(8):694-709. PubMed ID: 24018211
    [Abstract] [Full Text] [Related]

  • 8. [Psoriasis in special localizations].
    Schmieder A, Peitsch WK.
    Hautarzt; 2016 Jun 01; 67(6):454-63. PubMed ID: 27215754
    [Abstract] [Full Text] [Related]

  • 9. Complete response of secukinumab in palmoplantar psoriasis.
    Rocamora V, Garcías-Ladaria J.
    Dermatol Online J; 2017 Oct 15; 23(10):. PubMed ID: 29469799
    [Abstract] [Full Text] [Related]

  • 10. Systemic therapy in treating palmoplantar and scalp psoriasis: A systematic review and network meta-analysis.
    Zhang L, Su Y, Shucheng H, Wang L, Jiang X.
    J Am Acad Dermatol; 2024 Mar 15; 90(3):646-648. PubMed ID: 37977294
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The Use of Apremilast in Psoriasis: A Delphi Study.
    Carrascosa JM, Belinchón I, Rivera R, Ara M, Bustinduy M, Herranz P.
    Actas Dermosifiliogr (Engl Ed); 2020 Mar 15; 111(2):115-134. PubMed ID: 31864537
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Psoriatic nail disease: quality of life and treatment.
    Gupta AK, Cooper EA.
    J Cutan Med Surg; 2009 Mar 15; 13 Suppl 2():S102-6. PubMed ID: 19799826
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of systemic treatment agents on psoriatic nails: a comparative study.
    Demirsoy EO, Kıran R, Salman S, Cağlayan C, Aktürk AS, Bayramgurler D, Bilen N.
    J Drugs Dermatol; 2013 Sep 15; 12(9):1039-43. PubMed ID: 24002153
    [Abstract] [Full Text] [Related]

  • 17. Underdiagnosed and undertreated psoriasis: Nuances of treating psoriasis affecting the scalp, face, intertriginous areas, genitals, hands, feet, and nails.
    Merola JF, Qureshi A, Husni ME.
    Dermatol Ther; 2018 May 15; 31(3):e12589. PubMed ID: 29512290
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2).
    Rich P, Gooderham M, Bachelez H, Goncalves J, Day RM, Chen R, Crowley J.
    J Am Acad Dermatol; 2016 Jan 15; 74(1):134-42. PubMed ID: 26549249
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of adalimumab in difficult-to-treat psoriasis.
    Lanna C, Zangrilli A, Bavetta M, Campione E, Bianchi L.
    Dermatol Ther; 2020 May 15; 33(3):e13374. PubMed ID: 32246516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.